Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eisai Inc.
Children's Oncology Group
Eastern Cooperative Oncology Group
Istituto Ortopedico Rizzoli
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assiut University
St. Jude Children's Research Hospital
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Dana-Farber Cancer Institute
Columbia University
Children's Oncology Group
Children's Oncology Group
University of Iowa
Teva Branded Pharmaceutical Products R&D, Inc.
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)